Literature DB >> 28969994

Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemia.

Deepika S Darbari1, Kathleen J Vaughan2, Katherine Roskom2, Cassie Seamon2, Lena Diaw2, Meghan Quinn2, Anna Conrey2, Alan N Schechter3, Jennifer A Haythornthwaite4, Myron A Waclawiw5, Gwenyth R Wallen6, Inna Belfer7, James G Taylor8.   

Abstract

BACKGROUND AND AIMS: Pain is the hallmark of sickle cell anemia (SCA), presenting as recurrent acute events or chronic pain. Central sensitization, or enhanced excitability of the central nervous system, alters pain processing and contributes to the maintenance of chronic pain. Individuals with SCA demonstrate enhanced sensitivity to painful stimuli however central mechanisms of pain have not been fully explored. We hypothesized that adults with SCA would show evidence of central sensitization as observed in other diseases of chronic pain.
METHODS: We conducted a prospective study of static and dynamic quantitative sensory tests in 30 adults with SCA and 30 matched controls.
RESULTS: Static thermal testing using cold stimuli showed lower pain thresholds (p=0.04) and tolerance (p=0.04) in sickle cell subjects, but not for heat. However, SCA subjects reported higher pain ratings with random heat pulses (p<0.0001) and change in scores with temporal summation at the heat pain threshold (p=0.002). Similarly, with the use of pressure pain stimuli, sickle cell subjects reported higher pain ratings (p=0.04), but not higher pressure pain tolerance/thresholds or allodynia to light tactile stimuli. Temporal summation pain score changes using 2 pinprick probes (256 and 512mN) were significantly greater (p=0.004 and p=0.008) with sickle cell, and delayed recovery was associated with lower fetal hemoglobin (p=0.002 and 0.003).
CONCLUSIONS: Exaggerated temporal summation responses provide evidence of central sensitization in SCA. IMPLICATIONS: The association with fetal hemoglobin suggests this known SCA modifier may have a therapeutic role in modulating central sensitization.
Copyright © 2017 Scandinavian Association for the Study of Pain. All rights reserved.

Entities:  

Keywords:  Central sensitization; Fetal hemoglobin; Pain; Sickle cell anemia; Temporal summation

Mesh:

Substances:

Year:  2017        PMID: 28969994      PMCID: PMC5726893          DOI: 10.1016/j.sjpain.2017.08.001

Source DB:  PubMed          Journal:  Scand J Pain        ISSN: 1877-8860


  54 in total

1.  Utilization of analgesics in the multicenter study of hydroxyurea in sickle cell anemia: effect of sex, age, and geographical location.

Authors:  Samir K Ballas; Robert L Bauserman; William F McCarthy; Oswaldo L Castro; Wally R Smith; Myron A Waclawiw
Journal:  Am J Hematol       Date:  2010-08       Impact factor: 10.047

2.  Outpatient pain predicts subsequent one-year acute health care utilization among adults with sickle cell disease.

Authors:  Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Yingwei Yao; Marie L Suarez; Veronica Angulo; Diana J Wilkie
Journal:  J Pain Symptom Manage       Date:  2014-03-15       Impact factor: 3.612

3.  Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.

Authors:  C Patrick Carroll; Sophie Lanzkron; Carlton Haywood; Kasey Kiley; Megan Pejsa; Gyasi Moscou-Jackson; Jennifer A Haythornthwaite; Claudia M Campbell
Journal:  Am J Prev Med       Date:  2016-07       Impact factor: 5.043

4.  Quantitative sensory testing in fibromyalgia patients and in healthy subjects: identification of subgroups.

Authors:  I M Hurtig; R I Raak; S A Kendall; B Gerdle; L K Wahren
Journal:  Clin J Pain       Date:  2001-12       Impact factor: 3.442

5.  Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.

Authors:  Divyanshoo R Kohli; Yunfang Li; Sergey G Khasabov; Pankaj Gupta; Lois J Kehl; Marna E Ericson; Julia Nguyen; Vinita Gupta; Robert P Hebbel; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2010-03-19       Impact factor: 22.113

6.  Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.

Authors:  David M Cain; Derek Vang; Donald A Simone; Robert P Hebbel; Kalpna Gupta
Journal:  Br J Haematol       Date:  2011-12-15       Impact factor: 6.998

7.  Validation of the sickle cell disease pain burden interview-youth.

Authors:  William T Zempsky; Emily A O'Hara; James P Santanelli; Tonya M Palermo; Tamara New; Kim Smith-Whitley; James F Casella
Journal:  J Pain       Date:  2013-05-20       Impact factor: 5.820

8.  Mast cell activation contributes to sickle cell pathobiology and pain in mice.

Authors:  Lucile Vincent; Derek Vang; Julia Nguyen; Mihir Gupta; Kathryn Luk; Marna E Ericson; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2013-06-17       Impact factor: 22.113

Review 9.  Thinking beyond sickling to better understand pain in sickle cell disease.

Authors:  Deepika S Darbari; Samir K Ballas; Daniel J Clauw
Journal:  Eur J Haematol       Date:  2014-05-16       Impact factor: 2.997

10.  Cold hypersensitivity increases with age in mice with sickle cell disease.

Authors:  Katherine J Zappia; Sheldon R Garrison; Cheryl A Hillery; Cheryl L Stucky
Journal:  Pain       Date:  2014-06-03       Impact factor: 6.961

View more
  2 in total

1.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

2.  Preliminary evidence that hydroxyurea is associated with attenuated peripheral sensitization in adults with sickle cell disease.

Authors:  Janelle E Letzen; Sophie Lanzkron; Kasey Bond; Christopher Patrick Carroll; Jennifer A Haythornthwaite; Sabrina Nance; Claudia M Campbell
Journal:  Pain Rep       Date:  2019-03-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.